Viracta Therapeutics, Inc.

VIRX · OTC
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Assets
Cash & Equivalents$12,317$36,773$103,554$47,089
Short-Term Investments$41,374$54,270$0$0
Receivables$281$798$0$0
Inventory$0-$910$0$0
Other Curr. Assets$992$3,700$1,719$220
Total Curr. Assets$54,964$93,747$105,273$47,199
Property Plant & Equip (Net)$464$414$882$1,030
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$1,264$1,830$2,397$76
Total NC Assets$1,728$2,244$3,279$1,106
Other Assets$0$0$0$0
Total Assets$56,692$95,991$108,552$48,305
Liabilities
Payables$2,441$2,540$2,901$1,557
Short-Term Debt$25,556$556$381$1,365
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$10,376$6,915$5,802$3,362
Total Curr. Liab.$38,373$10,011$9,084$6,284
LT Debt$0$24,877$5,097$4,813
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$83,408
Total NC Liab.$0$24,877$5,097$88,221
Other Liabilities$0$0$0$0
Cap. Leases$282$278$659$992
Total Liabilities$38,373$34,888$14,181$94,505
Equity
Pref Stock$5,452$5,452$5,452$5,545
Common Stock$4$4$4$1
Retained Earnings-$265,932-$214,874-$165,677-$50,915
AOCI$9-$178$0-$5,545
Other Equity$278,786$270,699$254,592$4,714
Total Equity$18,319$61,103$94,371-$46,200
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$56,692$95,991$108,552$48,305
Net Debt$13,239-$11,340-$98,076-$40,911
Viracta Therapeutics, Inc. (VIRX) Financial Statements & Key Stats | AlphaPilot